HOBOKEN, New Jersey — Bullseye Biodevices, Inc. participated in the AATS International Thoracic Surgical Oncology Summit 2026 in New York City, represented by Dr. Donnie Mir, Co-Founder & CEO, and Dr. Jinho Kim, Co-Founder & CTO.

The team presented its work, “Multimodal Biosensing and Digital-Twin Modeling for Intraoperative Lung Tumor Localization,” highlighting the integration of mechanical stiffness, bioimpedance, and optical sensing with digital-twin modeling to support intraoperative tissue characterization and tumor localization.

The meeting provided a valuable opportunity to share the company’s progress and connect with surgeons, researchers, and industry leaders advancing thoracic oncology.